Clinical Trials on Flatus in Belgium

Total 14 results

University Hospital, Ghent

Terminated

Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Epilepsy

Status Epilepticus | Epilepsia Partialis Continua

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus

Status Epilepticus | Positron-emission Tomography | Ictal-interictal Continuum | Perfusion Weighted MRI | Perfusion CT

Belgium
Université Catholique de Louvain
Anticancer Fund, Belgium

Completed

Ketorolac in Breast Cancer Surgery (KBCt)

Curative Breast Cancer Surgery | Inflammatory Positive/Negative Status | Pre Surgical Incision Administration

Belgium
Thomas Jefferson University
Jawaharlal Nehru Medical College

Active, not recruiting

Neuroimaging Ancillary Study

Iron Deficiency Anemia | Child Development | Iron Deficiency Anemia of Pregnancy | Iron Deficiency Anemia Treatment | Neurodevelopmental Disorder of Foetus | Fetal Neurodevelopmental Disorder

India
Universitaire Ziekenhuizen KU Leuven
University Hospital, Ghent; University Hospital, Antwerp; Imelda Hospital, Bonheiden and other collaborators

Recruiting

Glucose Homeostasis, Metabolomics and Pregnancy Outcomes After Bariatric Surgery (GLORIA)

Bariatric Surgery Status Complicating Pregnancy

Belgium
MMI Spa

Recruiting

PRIMO Post-Market Clinical Follow Up Study (PRIMO)

Open Surgery | Blood Vessels, Lymphatic Ducts and Nerves | Free Flaps

Spain, Switzerland, Italy, Belgium, Austria, Germany
Erasme University Hospital

Recruiting

Sustained Effort Network for Treatment of Status Epilepticus/European Academy of Neurology Registry on Refractory Status Epilepticus (SENSE-II/AROUSE) (SENSEII/AROUSE)

Status Epilepticus

Norway, Switzerland, Finland, Austria, Belgium, Denmark, Germany, United Kingdom
Marinus Pharmaceuticals

Withdrawn

To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)

Refractory Status Epilepticus

Spain, Switzerland, Germany, France, Austria, Italy, Belgium, United Kingdom, Czechia, Croatia, Finland, Lithuania, Israel, Hungary, Poland, Slovakia
Assaf-Harofeh Medical Center

Recruiting

Develop a Multi-disciplinary Approach for a Personalized Prenatal Diagnostics and Care for Twin Pregnancies (PRETWINSCREN)

Premature Birth | Twin Pregnancy With Antenatal Problem | Twin Pregnancy, Antepartum Condition or Complication | Twin Dichorionic Diamniotic Placenta | Twin Monochorionic Monoamniotic Placenta | Twin; Pregnancy, Affecting Fetus or Newborn | Prenatal Disorder

Belgium, Canada, Germany, Israel, Spain, United Kingdom
Leiden University Medical Center
Karolinska University Hospital; Universitaire Ziekenhuizen KU Leuven; Boston... and other collaborators

Recruiting

Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation (CONTRAST)

Fetal Growth Retardation | Twin; Pregnancy, Affecting Fetus or Newborn | Twin Diseases | Twin Monochorionic Diamniotic Placenta

United States, Belgium, Netherlands, Sweden, Canada, Spain
University of Twente
Radboud University Medical Center; University Medical Center Groningen; Maastricht... and other collaborators

Completed

TELSTAR: Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation (TELSTAR)

Cardiac Arrest | Status Epilepticus | Anoxic Encephalopathy

Netherlands, Belgium
Labo'Life

Recruiting

Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts (EVAsION)

Plantar Wart | Common Wart | Flat Wart

Belgium
Janssen Research & Development, LLC

Active, not recruiting

A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregnant Women at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Hemolytic Disease of the Fetus and Newborn

United States, Canada, Netherlands, Belgium, Germany, Spain, Sweden, United Kingdom, Australia
Janssen Research & Development, LLC

Completed

A Study to Characterize the Clinical Course of Pregnant Women and Children at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn

Erythroblastosis, Fetal | Early Onset Severe Hemolytic Disease of the Fetus and Newborn (EOS-HDFN)

United States, Canada, Netherlands, Belgium, Australia, Germany, Spain, Sweden, United Kingdom

Clinical Trials on Flatus in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations